Effects of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Cardiomyopathy The incidence and prevalence of diabetes are increasing year by year globally, and patients with diabetes are at increased risk of cardiovascular disease and heart failure. Diabetic cardiomyopathy (DCM) refers to the presence of abnormal myocardial structure and performance in the absence of other heart-related risk factors (such as coronary artery-related disease, hypertension, and severe...
0 Shares
985 Views
0 Reviews